(October 04 23:34) Forbes.com
In January the Centers for Medicare and Medicaid Services (CMS) finalized a rule on coverage of breakthrough medical devices that would allow for coverage for four years. Last month, CMS reversed course, by proposing to rescind the rule due primarily to clinical evidence concerns.
You can find the original article
here